HCP inhibits the activity of tyrosinase and decreases the amount of proteins related with melanogenesis by antagonizing the effect α-MSH- and ET-1-induced on MNT-1 human melanoma cells and promoting the transfer to keratinocytes. The gene discussed is STAMBP; the disease is melanoma.